(Q43824344)

27 November 2017

Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin (English)

1 reference

27 November 2017

Fabel K

1

1 reference

27 November 2017

Dietrich J

2

1 reference

27 November 2017

Hau P

3

1 reference

27 November 2017

Wismeth C

4

1 reference

27 November 2017

Winner B

5

1 reference

27 November 2017

Przywara S

6

1 reference

27 November 2017

Steinbrecher A

7

1 reference

27 November 2017

Ullrich W

8

1 reference

27 November 2017

Bogdahn U

9

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

27 November 2017

1 reference

27 November 2017

92

1 reference

27 November 2017

7

1 reference

27 November 2017

1936-1942

1 reference

Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.

27 November 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1936%3A%3AAID-CNCR1712%3E3.0.CO%3B2-H

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1936%3A%3AAID-CNCR1712%3E3.0.CO%3B2-H

The role of chemotherapy in recurrent malignant gliomas: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1936%3A%3AAID-CNCR1712%3E3.0.CO%3B2-H

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1936%3A%3AAID-CNCR1712%3E3.0.CO%3B2-H

Chemosensitivity of glioma cells in vitro: a meta analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1936%3A%3AAID-CNCR1712%3E3.0.CO%3B2-H

Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1936%3A%3AAID-CNCR1712%3E3.0.CO%3B2-H

Response criteria for phase II studies of supratentorial malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1936%3A%3AAID-CNCR1712%3E3.0.CO%3B2-H

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1936%3A%3AAID-CNCR1712%3E3.0.CO%3B2-H

Chemotherapy response criteria in malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1936%3A%3AAID-CNCR1712%3E3.0.CO%3B2-H

A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1936%3A%3AAID-CNCR1712%3E3.0.CO%3B2-H

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1936%3A%3AAID-CNCR1712%3E3.0.CO%3B2-H

Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1936%3A%3AAID-CNCR1712%3E3.0.CO%3B2-H

Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1936%3A%3AAID-CNCR1712%3E3.0.CO%3B2-H

NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1936%3A%3AAID-CNCR1712%3E3.0.CO%3B2-H

Expression of multidrug resistance protein gene in patients with glioma after chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1936%3A%3AAID-CNCR1712%3E3.0.CO%3B2-H

Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1936%3A%3AAID-CNCR1712%3E3.0.CO%3B2-H

10.1002/1097-0142(20011001)92:7<1936::AID-CNCR1712>3.0.CO;2-H

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference